SE
Serina Therapeutics Inc
SER · AMEX
$2.49 -0.40% (-$0.01)
1M -6.37%
Market Cap $37.6M
P/E Ratio -
Div. Yield -
ROE 222.42%
Bulios Fair Price
$1.49
40.2% downside
Trenutna cena
$2.49
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SER trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
87 /100
Cheap P/B 2.01x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 222.42%
ROA 82.03%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 6.65x
Int. coverage -101.85x
Debt/Equity 0.17x
Stability
1 /100
Unstable Rev. volatility 363.57%
EPS volatility 237.11%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SER
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven A. Ledger
Employees
16
Headquarters
Huntsville
Prihajajoči dogodki
18 NOV.
Earnings
Upcoming earnings report